莫德納mRNA新冠肺炎疫苗Spikevax®- 開創mRNA新局引領全球防疫戰略

國際新創 - 生技製藥與精準醫療

2024-01-03

上一則

下一則

返回列表

｜

莫德納台灣股份有限公司

spikevax^TM是莫德納運用mRNA技術迅速開發出的Covid-19疫苗，2021年獲得台灣食藥署緊急授權。它利用基因指令來激發免疫反應來降低嚴重COVID-19疾病、住院和死亡的風險。 spikevaxTM的快速開發和應用為疫苗技術和公共衛生的重要里程碑。莫德納的mRNA平台使我們能夠迅速應對新興的COVID-19變種病毒株。為確保更新的疫苗可以對目前傳播的變種病毒株提供最佳的免疫反應，藥品監管機構和全球公共衛生組織建議在2023年6月將COVID-19疫苗更新為單價XBB.1.5組成。

Moderna’s Covid-19 vaccine spikevax^TM was developed rapidly using mRNA technology, and was authorized in 2021 in Taiwan. It utilizes genetic instructions to stimulate an immune response to reduce the risk of severe COVID-19 disease, hospitalization, and death. The swift development and deployment of spikevaxTM marked a significant milestone in vaccine technology and public health. The power of Moderna’s mRNA platform enables us to move quickly against emerging COVID-19 variants. To ensure updated vaccines provide the most robust immune response against the dominant circulating variants, regulators and global public health agencies recommended that COVID-19 vaccines be updated to a monovalent XBB.1.5 composition in June 2023.

評審推薦

1. 在新冠疫情爆發時，應用mRNA平台發展COVID-19 疫苗，有效降低 COVID-19 相關的重症、住院與死亡風險。
2. Spikevax®在全球超過70個國家核准使用，已生產超過10億支，估計在2021年幫助減少170萬因COVID-19死亡案例。
3. 2022年成立「莫德納台灣股份有限公司」，並開展與台灣醫療照護專家與學研機構的合作，為台灣民眾提供更多mRNA技術的健康方案。

公司簡介

莫德納是創造mRNA醫學領域的領導者。透過mRNA技術的推進，莫德納讓我們重新想像藥物的製造方式，轉變我們治療和預防疾病的方式，造福每一個人。在科學、技術和健康的領域努力了十多年，莫德納以前所未有的速度和效率開發藥物，包含最早且最有效的COVID-19疫苗。

莫德納的mRNA平台使得能夠開發用於傳染性疾病、免疫腫瘤學、罕見疾病和自體免疫疾病的治療和疫苗。憑藉獨特的文化，莫德納全球的團隊被公司的價值觀和思維所激發，負責任地改變人類健康的未來，莫德納致力透過mRNA療法為人們帶來最大可能的影響力。

Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.

Moderna's mRNA platform is enabling the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines.